PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3

Shaun Jackson, Simone Schoenwaelder

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here
Original languageEnglish
Title of host publicationPhosphoinositide 3-kinase in Health and Disease
EditorsChristian Rommel, Bart Vanhaesebroeck, Peter K Vogt
Place of PublicationUS
PublisherSpringer
Pages203 - 224
Number of pages22
Edition1st
ISBN (Print)9783642136627
Publication statusPublished - 2010

Cite this

Jackson, S., & Schoenwaelder, S. (2010). PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3. In C. Rommel, B. Vanhaesebroeck, & P. K. Vogt (Eds.), Phosphoinositide 3-kinase in Health and Disease (1st ed., pp. 203 - 224). US: Springer.
Jackson, Shaun ; Schoenwaelder, Simone. / PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3. Phosphoinositide 3-kinase in Health and Disease. editor / Christian Rommel ; Bart Vanhaesebroeck ; Peter K Vogt. 1st. ed. US : Springer, 2010. pp. 203 - 224
@inbook{3efabe95f3d443e2b63f31cc63958938,
title = "PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3",
abstract = "From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here",
author = "Shaun Jackson and Simone Schoenwaelder",
year = "2010",
language = "English",
isbn = "9783642136627",
pages = "203 -- 224",
editor = "Christian Rommel and Bart Vanhaesebroeck and Vogt, {Peter K}",
booktitle = "Phosphoinositide 3-kinase in Health and Disease",
publisher = "Springer",
edition = "1st",

}

Jackson, S & Schoenwaelder, S 2010, PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3. in C Rommel, B Vanhaesebroeck & PK Vogt (eds), Phosphoinositide 3-kinase in Health and Disease. 1st edn, Springer, US, pp. 203 - 224.

PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3. / Jackson, Shaun; Schoenwaelder, Simone.

Phosphoinositide 3-kinase in Health and Disease. ed. / Christian Rommel; Bart Vanhaesebroeck; Peter K Vogt. 1st. ed. US : Springer, 2010. p. 203 - 224.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3

AU - Jackson, Shaun

AU - Schoenwaelder, Simone

PY - 2010

Y1 - 2010

N2 - From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here

AB - From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here

UR - http://rd.springer.com/chapter/10.1007/82_2010_61

M3 - Chapter (Book)

SN - 9783642136627

SP - 203

EP - 224

BT - Phosphoinositide 3-kinase in Health and Disease

A2 - Rommel, Christian

A2 - Vanhaesebroeck, Bart

A2 - Vogt, Peter K

PB - Springer

CY - US

ER -

Jackson S, Schoenwaelder S. PI 3-Kinase p-110-beta regulation of platelet integrin alpha-II-beta-3. In Rommel C, Vanhaesebroeck B, Vogt PK, editors, Phosphoinositide 3-kinase in Health and Disease. 1st ed. US: Springer. 2010. p. 203 - 224